Nuclear cardiology in Singapore: A review

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 4, 2004, Pages 461-466

  Ching, C K ^a   Keng, F ^a   Chua, Terrance S J ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Myocardial perfusion imaging; Nuclear cardiology

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; 15 (4 IODOPHENYL)PENTADECANOIC ACID I 123; ADENOSINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; DIADENOSINE POLYPHOSPHATE; DIADENOSINE POLYPHOSPHATE TECHNETIUM TC 99M; ENDOTHELIN DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCARATE TECHNETIUM TC 99M; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY Z2D3; N ETHOXY N ETHYLDITHIOCARBAMATONITRIDO; SACCHARIC ACID; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG;

BLOOD VESSEL; CARDIOLOGY; CLINICAL TRIAL; DRUG HALF LIFE; GATED SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART MUSCLE SALVAGE; HEART SCINTISCANNING; HUMAN; IMAGING; MOLECULAR BIOLOGY; MOLECULAR IMAGING; MYCOARDIAL VIABILITY; NUCLEAR CARDIOLOGY; NUCLEAR MEDICINE; PROGNOSIS; RADIATION DOSE; REPORTER GENE; REVIEW; RISK ASSESSMENT; SINGAPORE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; TECHNIQUE; THORAX PAIN; VASCULAR IMAGING;

EID: 4644371964     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Sundram FX, Lam LK, Ang ES, Goh AS, Johan A, Tan AT, et al. Tomographic thallium-201 stress scintigraphy in the evaluation of coronary artery disease. Ann Acad Med Singapore 1986;15:471-5.
2. Lam LK, Tang KF, Sundram FX, Ang ES, Johan A, Chia BL, et al. Thallium-201 myocardial stress imaging: a study of its value in the diagnosis of coronary artery disease and the location of the diseased vessel. Singapore Med J 1987;28:6-12.
3. Woo BY, Sundram FX, Goh AS, Tan AT. Nuclear cardiology in the detection of coronary artery disease - an overview of its role in the Singapore General Hospital. Ann Acad Med Singapore 1990;19:104-7.
4. Chua T, Kiat H, Germano G, Maurer M, Van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107-14.
5. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated sestamibi SPECT. J Nuclear Med 1995:36:2138-47.
6. Nichols K, DePuey EG, Rowanski A. Automation of gated tomographic left ventricular ejection fraction. J Nucl Cardiol 1996;3:475-82.
7. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated Tc-99m sestamibi SPECT. J Nucl Med 1993;34: 1871-6.
8. Chua T, Lee CY, Tan HT, Tai BC, Ding ZP, Lim YL. Accuracy of automated assessment of left ventricular function using gated perfusion SPECT in the presence of perfusion defects and left ventricular dysfunction: correlation with equilibrium radionuclide ventriculography and echocardiography. J Nucl Cardiol 2000;7:301-11.
9. Chua T, Lee CY, Keng F, Ding ZP, Lim YL. Automated quantification of regional function by gated perfusion tomography: determination of a normal range and correlation with echocardiography for detection of abnormal wall motion [abstract]. J Am Coll Cardiol 2001;37:393A (ACC 2001).
10. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of TI-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
11. Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997;30:1687-92.
12. Brown KA. Prognosis in stable coronary artery disease. In: Zaret BL, Beller GA, editors. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby, 1999:331-45.
13. Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
14. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
15. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639-47.
16. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639-47.
17. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
18. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia: the Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 1999;33:661-9.
19. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, et al. Prognostic value of exercise thallium-201 imaging patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994-1001.
20. Brown KA, Heller GV, Landin RS, Shaw LJ, Beller GA, Pasquale MJ, et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2-4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-6.
21. INSPIRE results. Late-breaking clinical trials sessions at ACC 2004. J Am Coll Cardiol 2004. In press.
22. Hilton TC, Thompson RC, Williams HJ, Saylors R, Fulmer H, Stowers SA. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994; 23:1016-22.
23. Hilton TC, Fulmer H, Abuan T, Thompson RC, Stowers SA. Ninety-day follow-up of patients in the emergency department with chest pain who undergo initial single-photon emission computed tomographic perfusion scintigraphy with technetium 99m-labeled sestamibi. J Nucl Cardiol 1996;3:308-11.
24. Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993;22:1804-8.
25. Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997;29:116-25.
26. Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest techetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998;31:1011-7.
27. Udelson JE, Beshan JR RN, Ballin, Feldman JA, Griffith JL, Handler J, et al. Myocardal perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial [Published erratum in JAMA 2003;289:178]. JAMA 2002;288: 2693-700.
28. Udelson JE, Beshan JR RN, Ballin, Feldman JA, Griffith JL, Handler J, et al. Myocardal perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial [Published erratum in JAMA 2003;289:178]. JAMA 2002;288: 2693-700.
29. Keng FY, Chua TS, Goh AS, Ang ES, Sundram FX, Tan AT. Technetium-99m sestamibi for the assessment of myocardial salvage following reperfusion therapy in acute myocardial infarction. Ann Acad Med Singapore 2000:29:224-30.
30. Siebelink HM, Blanksma PK, Crijns HJ, Bax JJ, van Boven AJ, Kingma T, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardial. J Am Coll Cardiol 2001;37:81-8.
31. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
32. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischaemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96:793-800.
33. Pasquet A, Robert A, D'hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischaemia and viability in patients with chronic left ventricular ischaemic dysfunction. Circulation 1999;100:141-8.
34. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759-62.
35. DiCarli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
36. DiCarli MF, Asgarzadi EF, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995:92:3436-44.
37. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW, Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8.
38. Sinusas AJ. New approaches to myocardial imaging with hypoxia markers. In: Iskandrian AS, editor. New Developments in Cardiac Nuclear Imaging. Armonk, NY: Futura Publishing Co, 1998:203-18.
39. Okasa RD, Johnson G III, Nguyen KN, Carlson LR, Beju D. HL-91-technetium-99m: a new marker of viability in ischemic myocardium. J Nucl Cardiol 1999;6:306-15.
40. He ZX, Shi RF, Wu YJ, Tian YQ, Liu XJ, Wang SW, et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 2003;108:1208-13.
41. Tamaki N, Kudoh T, Tadamura E. Fatty acid imaging. In: Zaret BL, Beller GA, editors. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby, 1999:573-86.
42. Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Circulation 1997;95:1577-84.
43. Narula J, Petrov A, Bianci C, Ditlow CC, Lister BC, Dilley J, et al. Noninvasive localisation of experimental atherosclerosis lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscles of human atheroma; imaging with conventional and negative charge-modified antibody fragments. Circulation 1995;92: 474-84.
44. Carrio I, Pieri PL, Narula J, Prat L, Riva P, Pedrini L, et al. Noninvasive localisation of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol 1998;5:551-7.
45. Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Radiolabeled MDA2, an oxidation-specific monoclonal antibody, identifies native atherosclerotic lesion in vivo. J Nucl Cardiol 1999;6: 41-53.